Table. ESBL-producing Enterobacteriaceae recovered from sachet-packaged water bags in Kinshasa, Democratic Republic of the Congo*.
Isolate no. | Species | Microarray CT101 result | Associated resistance† |
Folate PI | |
---|---|---|---|---|---|
Aminoglycosides | Fluoroquinolones | ||||
44 | Citrobacter freundii | CTX-M1 group | AMK, GEN, TOB | CIP, LEV, MXF, NXN | T/S |
48 | Citrobacter freundii | CTX-M1 group | AMK, GEN, TOB | CIP, LEV, MXF, NXN | T/S |
152 | Enterobacter cloacae | SHV G238S (SHV-2 like) | NA | NA | T/S |
154 | Klebsiella pneumoniae | CTX-M1 group | GEN, TOB | CIP, MXF | T/S |
163 | Citrobacter freundii | CTX-M1 group | NA | MXF | T/S |
165 | Klebsiella pneumoniae | CTX-M1 group | GEN, TOB | NA | T/S |
170 | Klebsiella pneumoniae | SHV G238A+E240K(SHV-18) | GEN, TOB | MXF | NA |
171 | Escherichia coli | SHV G238A+E240K(SHV-18) | GEN, TOB | NA | NA |
*ESBL, extended-spectrum β-lactamase; PI, pathway inhibitors; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; LEV, levofloxacin; MXF, moxifloxacin; NXN, norfloxacin; T/S, trimethoprim/sulfamethoxazole; NA, not applicable. †Based on interpretive breakpoints as indicated in Clinical and Laboratory Standards Institute guidelines M100-S18, published January 2008.